new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Eisai R & d Management Co Ltd patents

Recent patent applications related to Eisai R & d Management Co Ltd. Eisai R & d Management Co Ltd is listed as an Agent/Assignee. Note: Eisai R & d Management Co Ltd may have other listings under different names/spellings. We're not affiliated with Eisai R & d Management Co Ltd, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "E" | Eisai R & d Management Co Ltd-related inventors




Date Eisai R & d Management Co Ltd patents (updated weekly) - BOOKMARK this page
03/16/17Use of eribulin and mtor inhibitors as combination therapy for the treatment of cancer
01/12/17Pyrimidine fgfr4 inhibitors
01/05/17Revascularization graft material
12/29/16Compounds useful in the synthesis of halichondrin b analogs
12/01/16Tetrasubstituted alkene compounds and their use
12/01/16Anti human notch4 antibody
11/24/16Tetrahydropyrazolopyrimidine compounds
11/10/16Cationic lipid
11/10/16Selectively substituted quinoline compounds
11/03/16Methods and compounds useful in the synthesis of orexin-2 receptor antagonists
10/20/16Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain
10/06/16Pyridinylpyrazoloquinoline compounds
10/06/16Methods for prognosing the ability of a zearalenone analog compound to treat cancer
09/15/16Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b
08/25/164-azaindole derivatives
08/18/16Hydrochloride salt form for ezh2 inhibition
08/11/16Method of treating cancer
08/04/16Fluorescent probe for imaging lymph nodes
07/28/16Intermediates and methods for the synthesis of halichondrin b analogs
07/28/16Method for inducing dopaminergic neuron progenitor cells
06/23/16Selectively substituted quinoline compounds
06/23/16Methods useful in the synthesis of halichondrin b analogs
06/16/16Hetero-fused cyclic compound
05/12/16Pyrimidine fgfr4 inhibitors
03/31/16Immunostimulatory compound
03/31/16Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
02/25/16Tetrahydroimidazo[1,5-d][1,4]oxazepine compound
02/18/16[11c] and [18f] labeled 1,3-diphenyl-5-(pyrimidin-2-yl)-pyridin-2(1h)-one derivatives and their use for pet imaging of the ampa receptor
02/18/16Salt of pyrazoloquinoline derivative, and crystal thereof
02/18/16Neutralizing anti-ccl20 antibodies
02/04/16Tetrahydropyrazolopyrimidine compounds
01/14/16Abeta protofibril binding antibodies
01/07/16Salt of pyrrolidin-3-yl acetic acid derivative and crystals thereof
11/19/15Pladienolide pyridine compounds and methods of use
11/05/15Halichondrin b analogs
10/22/15Lrp4/corin dopamine-producing neuron precursor cell marker
10/22/15Rna detection method and detection kit
10/15/15Amorphous form of quinoline derivative, and producing same
10/01/15Neural stem cell having increased passage ability, manufacturing neural stem cell having said increased passage abiility, and culturing neural stem cells for increasing passage ability of neural stem cells
08/20/15Intermediates for the preparation of analogs of halichondrin b
08/13/15Intermediates and methods for the synthesis of halichondrin b analogs
07/02/15Multikinase inhibitors for use in the treatment of cancer
06/25/15(6s,9as)-n-benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-(methyl)-2-(prop-2-en-1-yl)-octahydro-1h-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide compound
06/25/15Compounds useful in the synthesis of halichondrin b analogs
06/11/15Methods useful in the synthesis of halichondrin b analogs
04/30/15Capsule formulation
04/16/15Selectively substituted quinoline compounds
04/02/154-azaindole derivatives
03/26/15Method for producing 5-(difluoromethyl)pyrazine-2-carboxilic acid and production intermediate thereof
03/05/15Salt form of a human histone methyltransferase ezh2 inhibitor
02/26/15Methods for detecting th1 cells
01/01/15Use of eribulin and lenvatinib as combination therapy for treatment of cancer
12/18/14Novel indanesulfamlde derivatives
10/30/14Compounds for preparing immunological adjuvant
08/28/14Tetrahydroimidazo(1,5-d)[1,4]oxazepine derivative
08/21/14Monocyclic pyridine derivative
08/21/14Methods and compositions for predicting response to eribulin
08/07/14Intermediates for the preparation of analogs of halichondrin b
07/10/14Anti-human xcr1 antibodies
07/03/14Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
06/26/14Fused aminodihydrothiazine derivatives
06/12/14Use of eribulin in the treatment of breast cancer
06/12/14Intermediates for the preparation of analogs of halichondrin b
06/12/14Halichondrin b analogs
06/05/14Pharmaceutical composition
Patent Packs
05/29/14Method for predicting effectiveness of angiogenesis inhibitor
05/22/14Fused aminodihydrothiazine derivatives
05/22/14Method for producing 1,2-dihydropyridine-2-one compound
04/10/14Composition containing two anti-dementia drugs
03/20/14Method for detecting neurological disease associated with cognitive impairment by measuring epha4 extracellular domain
03/06/14Compositions and methods for cancer immunotherapy
02/13/14Liposome composition
01/30/14Therapeutic agent for tumor
01/23/14Method for screening for compound capable of enhancing or inhibiting oatp1b1 transport activity, and determining expression level of oatp1b1
01/09/14Fused aminodihydrothiazine derivatives
01/09/14Method for producing phenoxypyridine derivative
01/09/14Compounds for preparing immunological adjuvant
11/14/13Multikinase inhibitors for use in the treatment of cancer
10/31/13Screening method using gelatinase-mediated epha4 cleavage reaction as an indicator
10/31/13Combined pharmaceutical composition as antifungal agent
Patent Packs
10/10/13Biomarker for alzheimer`s disease or mild cognitive impairment
09/12/13Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide
09/12/13Pharmaceutical composition
09/12/13Intermediates for the preparation of analogs of halichondrin b
09/05/13Methods for detecting th1 cells
09/05/13Methods for detecting th1 cells
08/15/13Intermediates and methods for making zearalenone macrolide analogs
08/08/13Fused aminodihydrothiazine derivatives
08/08/13Fused aminodihydrothiazine derivatives
08/01/13Sitaxentan derivative
08/01/13Paroxetine derivative
08/01/13Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
07/25/13Compressed composition
07/18/13Anti-folate receptor alpha antibodies and uses thereof
06/06/13Pyrazoloquinoline derivatives
05/16/13Antitumor agent using compounds having kinase inhibitory effect in combination
04/18/13Agent for treating hcv infection
04/18/13Method for producing tumor cells from normal mammary epithelial cells
04/04/13Method for assay on the effect of vascularization inhibitor
03/14/13Pyrrolidin-3-ylacetic acid derivative
02/28/13Prodrug of triazolone compound
12/06/12Intermediates for the preparation of analogs of halichondrin b
09/13/12Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
08/23/12Compositions and methods for treating inflammatory disorders
08/09/12Fused aminodihydro-oxazine derivatives
08/09/12Fused aminodihydropyrimidone derivatives
07/26/12Fused aminodihydrothiazine derivatives
07/12/12Specific marker lmx1a on dopaminergic neurons
06/28/12Cyclopropane derivatives
05/24/12Method of manufacture of liposome composition
Social Network Patent Pack
04/19/12Fused aminodihydrothiazine derivatives
04/19/12Cyclopropane compound
04/19/12Intermediates and methods for the synthesis of halichondrin b analogs
03/29/12Anti-tumor agent
03/29/12Quinoline derivative-containing pharmaceutical composition
03/08/12Liposome composition
02/02/12Trapping compounds and identifying reactive metabolites
02/02/12Intermediates for the preparation of analogs of halichondrin b
01/26/12Dopaminergic neuron proliferative progenitor cell marker nato3
01/05/12Method for controlled release of an acid-unstable physiologically active substance
Patent Packs
12/01/11Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
12/01/11Methods for detecting th1 cells
10/27/11Method for manufacturing heterocycle substituted pyridine derivatives
10/20/11Method for obtaining pancreatic progenitor cell using neph3
10/13/11Compositions and methods for cancer immunotherapy
10/06/11Compositions and methods for immunotherapy
09/29/11Intermediates and methods for making zearalenone macrolide analogs
09/22/11Dopaminergic neuron proliferative progenitor cell marker msx1/2
08/25/11Novel fused aminodihydrothiazine derivative
08/25/11Antitumor agent for thyroid cancer
08/18/11Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites
08/18/11Method for obtaining purkinje progenitor cell by using neph3(65b13) and e-cadherin
08/11/11Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
07/28/11Method for screening of substance effective on disease using gpr120 and phospholipase
07/28/11Benzoxazole compounds and methods of use
07/28/11Compounds useful in the synthesis of halichondrin b analogs
07/14/11Polymer for detection of target substance, and detection of target substance
07/14/11Process for preparing certain cinnamide compounds
06/23/11Spiroaminodihydrothiazine derivatives
06/23/11Reagents and methods for preparing lps antagonist b1287 and stereoisomers thereof
06/23/11Method for producing quinazoline derivative
06/09/11Novel collagen-like protein clac, precursor thereof and genes encoding the same
06/02/11Highly purified antiendotoxin compound
05/12/11Method of screening for compounds which affect the processing of epha4 by gamma-secretase
05/05/11Epha4 polypeptide having a novel activity and use thereof
04/14/11Pyrazolothiazole compound
04/14/11Pyrazolooxazole compound
03/17/11Method for examination of alzheimer's disease
03/03/11Methods and compositions using cholinesterase inhibitors
03/03/11Halichondrin b analogs
Patent Packs
02/24/11Matrix type sustained-release preparation containing basic drug or salt thereof and, manufacturing the same
02/24/11Intermediates in the synthesis zearalenone macrolide analogs
01/27/11Novel preparation for external use
01/13/11Dopaminergic neuron progenitor cell marker 187a5
01/13/11Polycyclic compound
12/30/10Non-human gene-disrupted animal with disrupted adam11 gene
12/23/10Methods of selecting a dopaminergic neuron proliferative progenitor cells using lrp4/corin markers
12/23/10Combined use of angiogenesis inhibitor and taxane
11/25/10Ampa receptor antagonists for epilepsy, mental disorders or deficits in sensory organ
11/11/10Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
11/04/10Methods of reducing the severity of mucositis
10/07/10Screening method utilizing novel substrate epha7 for gamma-secretase
10/07/10Ampa receptor antagonists and zonisamide for epilepsy
09/23/10Set of yeast cells, identifying target candidate molecule, analyzing action mechanism and screening method
09/09/10Substituted liposaccharides useful in the treatment and prevention of endotoxemia
09/09/10Method of screening substance useful in treating disease with the use of gpr40 and phospholipase
08/26/10Mammalian prickle gene
08/12/10Dopaminergic neuron proliferative progenitor cell marker msx1/2
08/12/10Gene specifically expressed in postmitotic dopaminergic neuron precursor cells
08/05/10Nitrogen-containing aromatic derivatives
Social Network Patent Pack
07/29/10Tubulin isotype screening in cancer therapy using halichondrin b analogs
07/15/10Ampa receptor antagonists and zonisamide for neuropathic pain
07/01/10Combination of ampa receptor antagonists and acetylcholinesterase inhibitors for the treatment of neuropathic pain
06/17/10Sodium salt of disaccharide compound, producing the same, and use of the same
06/17/10Method for stabilizing anti-dementia drug
05/27/10Cinnamide compounds for dementia
04/22/10Ampa and nmda receptor antagonists for neurodegenerative diseases
04/15/10Method for assay on the effect of vascularization inhibitor
04/15/10Novel fused aminodihydrothiazine derivative
04/15/10Composition containing stability-improved chloromethyl phosphate derivative and process for producing same
04/08/10Method for assaying action of antitumor agent using decrease in gene expression level as index
03/18/107-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
03/18/10Use of 7-azaindoles in the inhibition of c-jun n-terminal kinase
02/04/10Dopaminergic neuron proliferative progenitor cell marker nato3
01/28/10Method for assaying action of antitumor agent using splicing defects as index
01/21/10Production process of 2,3'-bipyridyl-6'-one
01/07/10Method of measuring moisture content of an object for drying
01/07/10Saspase knockout animal
12/31/09Fungal cell wall synthesis gene
12/24/09Benzisoxazole compound
Social Network Patent Pack
11/26/09Eponemycin and epoxomicin analogs and uses thereof
11/12/09Cinnamide compound
10/29/09Bicycloamine derivatives
10/29/092,3-dihydro-iminoisoindole derivatives
09/17/09Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
09/17/09Method of evaluating effect of prolonging qt interval in electrocardiogram
09/10/09Receptor tyrosine kinase inhibitors comprising pyridine and pyrimidine derivatives
08/27/09Cyclic amidine derivatives
08/13/09Pharmaceutical composition for treating bulimia and depression arising from bulimia
08/13/09Novel intermediate for halichondrin b analog synthesis and novel desulfonylation reaction used for the intermediate
07/23/09Compounds and methods for treating toll-like receptor 2-related diseases and conditions
07/16/09Imidazo[1,2-b]pyridazine compound
07/09/09Pharmaceutical composition for treating esophageal cancer
07/02/09Methods for prognosing the ability of a zearalenone analog compound to treat cancer
06/25/09Intermediate in production of [2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine compound
06/18/091,2-di(cyclic group)substituted benzene derivative
06/18/09Composition containing higher fatty acid derivative and foods and drinks
06/11/09Process for production of lipid a analogue
05/28/09Micelles
05/07/09Composition containing stability-improved chloromethyl phosphate derivatve and process for producing same
05/07/09Fungal cell wall synthesis gene
04/16/09Fungal cell wall synthesis gene
04/02/09Presynaptic protein cast
04/02/09Crystal of 1,2-dihydropyridine compound (type iv)
03/26/09Multikinase inhibitors for use in the treatment of cancer
03/19/09Immunochemical determination method and determination reagent for cytochrome
03/05/09Crystals, amorphous substances or salts of methyl n-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid
02/19/09Prodrug of cinnamide compound







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Eisai R & d Management Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Eisai R & d Management Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';